| Severe SARI patients (i.e., cases) (n = 38) | Non-severe SARI patients (i.e., controls) (n = 122) |  | p valuea | |
---|---|---|---|---|---|
 | Median + IQR | Total | Median + IQR | Total |  |
Age (years) | 77.5 (67.5–82) | 38 | 77.5 (61–84) | 122 | 0.94 |
Sampling period (weeks) | 5 (4.25–6) | 38 | 5 (4–6) | 122 | 0.31 |
 | Proportion | Total | Proportion | Total |  |
Males | 0.54 | 37 | 0.48 | 119 | 0.58 |
Vaccinated | 0.53 | 19 | 0.34 | 71 | 0.18 |
Chronic cardiovascular condition | 0.47 | 38 | 0.29 | 122 | 0.047 |
Chronic respiratory condition | 0.39 | 38 | 0.20 | 122 | 0.02 |
Renal insufficiency | 0.34 | 38 | 0.16 | 122 | 0.02 |
Hepatic insufficiency | 0.03 | 38 | 0.04 | 122 |  > 0.99 |
Immunocompromised condition | 0.26 | 38 | 0.10 | 122 | 0.02 |
Pregnant | 0.00 | 38 | 0.02 | 122 | / |
Asthma | 0.00 | 38 | 0.06 | 122 | / |
Neuromuscular condition | 0.11 | 38 | 0.12 | 122 |  > 0.99 |
Diabetes | 0.18 | 38 | 0.15 | 122 | 0.61 |
Obesity | 0.08 | 38 | 0.11 | 122 | 0.76 |